Belgium considers broader access to GLP-1 drugs amid rising obesity burden

Experts in Belgium call for expanded reimbursement for GLP-1 medications, citing their potential to prevent serious health conditions and improve patients’ quality of life, as current criteria may be too restrictive amid rising obesity rates. Belgium is facing a growing…













